Cargando…

A clinically applicable molecular-based classification for endometrial cancers

BACKGROUND: Classification of endometrial carcinomas (ECs) by morphologic features is inconsistent, and yields limited prognostic and predictive information. A new system for classification based on the molecular categories identified in The Cancer Genome Atlas is proposed. METHODS: Genomic data fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talhouk, A, McConechy, M K, Leung, S, Li-Chang, H H, Kwon, J S, Melnyk, N, Yang, W, Senz, J, Boyd, N, Karnezis, A N, Huntsman, D G, Gilks, C B, McAlpine, J N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506381/ https://www.ncbi.nlm.nih.gov/pubmed/26172027 http://dx.doi.org/10.1038/bjc.2015.190

Ejemplares similares

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care
por: Talhouk, A., et al.
Publicado: (2016)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
por: Kommoss, Felix KF, et al.
Publicado: (2018)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival
por: Kamal, A M, et al.
Publicado: (2016)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
por: Hughes, Christopher S., et al.
Publicado: (2016)

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2012)

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
por: Ino, K, et al.
Publicado: (2006)

Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
por: Cummings, M, et al.
Publicado: (2015)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approach
por: Taylor, S E, et al.
Publicado: (2011)

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma
por: Schueneman, A, et al.
Publicado: (2015)

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
por: Bashashati, Ali, et al.
Publicado: (2013)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters
por: Versluis, M A, et al.
Publicado: (2015)

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas
por: Haldorsen, I S, et al.
Publicado: (2014)

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
por: Mori, N, et al.
Publicado: (2010)

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer
por: Gowardhan, B, et al.
Publicado: (2005)

Impact of genomic stability on protein expression in endometrioid endometrial cancer
por: Lomnytska, M I, et al.
Publicado: (2012)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
por: Krakstad, C, et al.
Publicado: (2012)

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
por: Sengal, Asmerom T, et al.
Publicado: (2022)

Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease
por: Darby, S, et al.
Publicado: (2009)

Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
por: Herath, N I, et al.
Publicado: (2009)

The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
por: Shoji, K, et al.
Publicado: (2009)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
por: Armstrong, K, et al.
Publicado: (2011)

Molecular profiling of cervical cancer progression
por: Hagemann, T, et al.
Publicado: (2007)

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
por: Jamieson, Amy, et al.
Publicado: (2021)

Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK
por: Hibbitts, S, et al.
Publicado: (2006)

The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer
por: Hettiaratchi, A, et al.
Publicado: (2007)

Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies
por: Hampson, L, et al.
Publicado: (2009)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention
por: Hanley, Gillian E., et al.
Publicado: (2022)

Acute organ injury is associated with alterations in the cell-free plasma transcriptome
por: Boyd, John H, et al.
Publicado: (2014)

Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy
por: Fu, Q, et al.
Publicado: (2014)

Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients
por: Hussien, M M I, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ap9j4cpv051aqiocu9qbhf4qqq